glp-1 agonist dpp 4 inhibitor DPP-4 inhibitors in the treatment of type 2 diabetes DPP4 Inhibitors vs GLP-1 Agonists

The SELECT trial (17,000+ adults with overweight/obesity and heart disease, but no diabetes) showed semaglutide reduced major cardiovascular events by 20% and a portion of that benefit didnt correlate with how much weight participants lost

Systolic and diastolic blood pressures were measured (Cardiomax II, Instruments, Columbus, OH) from the aorta, via the femoral artery, under pentobarbital anesthesia (50 mg/kg, administered intraperitoneally)

Adv Therapy

The report highlights a female AA patient in her 30s with a history of moderate AD, who, despite undergoing multiple treatments for AA without significant improvement, experienced hair growth within 2 weeks of initiating weekly subcutaneous injections of adalimumab